Clinician’s Guide to Cardio-Oncology: Best Practice and Future Directions
Hosted by the Washington University and Barnes-Jewish Heart & Vascular Center, “Clinician’s Guide to Cardio-Oncology: Best Practice and Future Directions” was presented on November 10, 2018 in Chicago, Illinois. This event was not part of the official Scientific Sessions 2018 as planned by the AHA committee on Scientific Sessions Program.
Presentation topics included monitoring and managing vascular toxicity, leveraging big data and the EHR to better inform cardio-oncology, comprehensive cardiac MRI safety, the utility for Echo/Global Longitudinal strain in cardiotoxicity, and the treatment of Amyloidosis.
Mayo Clinic cardiologist, Joerg Herrmann, MD, provides a review of the three main types of presentation of vascular toxicity seen with chemotherapy: acute vasospasm, acute thrombosis, and accelerated atherosclerosis.
Washington University cardiologist, John Gorcsan, MD, discusses how echocardiographic strain imaging has emerged as an important noninvasive tool to assist in monitoring for chemotherapy cardiotoxicity.